January 17, 2025

Patient Care Declines After PE Acquisition

A recent study reveals that patient-reported care experience declined significantly at hospitals acquired by private equity firms, highlighting the potential impact of private equity acquisitions on patient care.

Conexiant

January 17, 2025

Predictive Model for Difficult Psoriatic Arthritis Treatment

"According to the predictive model, the proposed D2T PsA definition identified a small subset of patients with increased treatment difficulty. These findings highlight the need for refining the criteria to better define D2T PsA patients."

Conexiant

January 16, 2025

Bone Density Risks in Cancer Survivors

Discover how cancer treatments, lifestyle factors, and comorbidities contribute to long-term bone mineral density deficits in childhood cancer survivors.

Conexiant

January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

January 15, 2025

Gene Study Reveals New Osteoarthritis Targets

"This study represents a major breakthrough for OA research by providing potential explanations for 13 OA GWAS risk loci."

Conexiant

January 14, 2025

Does Screening Cut Hip Fracture Risks?

"Screening in higher-risk women 65 years or older was associated with a small absolute risk reduction in hip and major fractures compared with usual care."

Conexiant

January 14, 2025

Tacrolimus Versus Infliximab: Remission and Colectomy in UC

Comparative outcomes of tacrolimus and infliximab for remission induction and colectomy rates in refractory UC.

Conexiant

January 14, 2025

Remnant Cholesterol as Biomarker for Endometriosis, Study

‘An increase of one unit in RC was linked to a 135% rise in the likelihood of developing endometriosis,’ positioning remnant cholesterol as a promising marker for risk assessment.

Conexiant

January 13, 2025

JAK Inhibitors & RZV Vaccination Timing: Study Underway

"The risk of developing herpes zoster is confirmed in almost all studies regarding JAK inhibitors."

Conexiant